Pak political drama nears end after army chief intervenes

August 29, 2014

Islamabad, Aug 29: Pakistan's powerful army chief has stepped in to mediate between the embattled government and the protesters seeking resignation of Prime Minister Nawaz Sharif, bringing the military back into the centre stage and signaling a possible end to the high-political drama.

Chairman Imran KhanPakistan Tehreek-i-Insaf (PTI) chairman Imran Khan and Pakistan Awami Tehreek (PAT) chief Tahirul Qadri, camping here for more than two weeks, met with army chief Gen Raheel Sharif in Rawalpindi overnight after the PML-N government asked him to play his "role" in ending the political crisis.

Khan wants the PML-N government's ouster over alleged rigging in last year's poll which his party lost, while Qadri wants to bring a revolution in the country.

According to well places sources, Interior Minister Nisar Ali Khan was also present during these meetings.

"It was agreed that army negotiators will have backdoor interactions with both sides today and prepare ground for an agreement between the two sides," sources said.

The government representatives will also meet the protest leaders and they will approve or sign the agreement mediated by the army.

After meeting Gen Sharif, Khan told his weary protesters that army has become "neutral umpire" in the crisis.

He still demanded resignation of the Prime Minister. "If he resigns we will celebrate it on Friday evening," he said.

Qadri also addressed his listless crowd of followers and said he had presented his revolutionary agenda to the army chief in the meeting.

Sources said that the deal brokered by army will address Khan's concerns about rigging and Qadri's basic demand of inclusion of clauses of anti-terror laws in the case already registered against Prime Minister Sharif, his brother and Punjab Chief Minister Shahbaz Sharif and others in Lahore.

Sharif is expected to survive in the political battle but he will become weak and unable to challenge army's grip on foreign and security policy of the country.

The army, which has so far been passive in the confrontation between the government and protesters, has a history of capturing power from democratically elected governments.

Sharif himself was removed from office during a previous stint as prime minister in a military coup by the then army chief Gen Pervez Musharraf in 1999.

When politician differed in 1977 over the outcome of polls, then army chief Gen Zia-ul Haq imposed martial law.

Meanwhile, leaders from across the political spectrum regretted the political tug of war that led to a crisis where the army got involved to settle dispute.

"After this, we will not be able to hold our heads high," Tehreek-i-Insaf leader Javed Hashmi, who is known for his outspoken opposition to military's involvement in politics, was quoted as saying by the Dawn.

"It is shameful time for all politicians who, despite having the time, could not resolve the crisis on their own."

Rightwing Jamaat-e-Islami chief Sirajul Haq had a more cautious response. He told a TV channel that if the army could intercede and end this crisis, well and good, but the military had no role in politics.

Jamiat Ulem-e-Islam-Fazal spokesperson Jan Achakzai had a similar response. "It is a failure of the politicians who could not resolve the crisis. But I welcome any deal that remains within the spirit of democracy and the Constitution."

Pakistan People's Party (PPP) leader Syed Khursheed Shah, who is also leader of the opposition in the National Assembly, said he would ask the prime minister why the army chief had to be asked to mediate when nearly all political parties were present in the house and had offered their support to him.

Former Punjab Governor and PPP leader Latif Khosa put the onus of the military's involvement squarely on the ruling PML-N's shoulders.

"After killing 14 innocent PAT workers, the Sharif brothers were unwilling even to register their FIR," he said, adding that the government's delaying tactics in dealing with PAT and PTI further complicated the situation.

Talking to DawnNews, prominent lawyer and rights activist Asma Jahangir criticised both Qadri and Khan, saying "Those who had wasted 15 days must be discouraged."

Nearly all parliamentary parties and politicians pleaded with them, but they did not heed anyone's advice, she said.

"Now, on a single phone call, they rush to Army House."

She criticised army's blatant involvement in political affairs and said instead of using their proxies to destabilise the system, why don't they impose direct military rule.

Secular Awami National Party Haji Adeel said it is wrong to make the military a political guarantor; parliament is the supreme guarantor.

"This is a major failure for all politicians," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Melbourne, Apr 10: Scientists have identified six drug candidates from more than 10,000 compounds that may help treat COVID-19.

The research, published in the journal Nature, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.

"Currently there are no targeted therapeutics or effective treatment options for COVID-19," said Professor Luke Guddat from the University of Queensland in Australia.

"In order to rapidly discover lead compounds for clinical use, we initiated a programme of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus," Guddat said.

The project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication, the researchers said.

This makes it an attractive drug target for this virus, and as people don't naturally have this enzyme, compounds that target it are likely to have low toxicity, they said.

"We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus. If the amount is small, then we have a promising compound for further studies," said Guddat.

After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.

"We're particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer," Guddat said.

Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.

"With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future," Guddat said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 18,2020

Washington, Feb 18: The upcoming visit of President Donald Trump to India later this month has the potential to usher in a new era of bilateral ties between the two countries, a top American business advocacy group has said.

President Trump will pay a state visit to India on February 24 and 25 at the invitation of Prime Minister Narendra Modi. He would be accompanied by First Lady Melania Trump.

This would be the president's first bilateral visit in the third decade of the 21st century and also the first after his acquittal by the Senate in the impeachment trial.

"I believe President Trump's upcoming visit to India has the potential to usher in a new era of our bilateral ties," Mukesh Aghi, President of the US India Strategic and Partnership Forum (USISPF) said in a statement on Monday.

On the sidelines of the visit, the USISPF, in collaboration with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the ORF, has announced to organise a program entitled "US-India Forum: Partners for Growth".

The full-day discussion will focus on the key pillars defining India and the US' strategic, economic, and cultural partnership over the next decade.

"We have an opportunity before us to make real progress on multiple aspects of the relationship— whether it is upholding peace and security in the Indo-Pacific region; building upon an already strong energy partnership; developing co-production and co-development opportunities in the defense space; or strengthening bilateral trade," Aghi said.

"We look forward to an extremely successful visit and some concrete outcomes from the visit," he said.

The day-long programme on February 25 in New Delhi, will bring together over 500 senior business executives, members of the US-India think tank community and leading figures of the Indian diaspora to set the agenda for this strategic partnership.

Discussions during the day will touch upon areas, including the Indo-Pacific Strategy and Maritime Security; the US-India Defence Partnership, the US-India Energy Partnership, Elevating US-India Trade and Investment and Role of the Indian Diaspora in US-India Relations.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 1,2020

Washington, Jul 1: The United States has approved four coronavirus vaccine candidates for clinical trials, Food and Drug Administration (FDA) head Stephen Hahn told reporters.

"Four vaccines have been approved for moving into clinical trials... and another six are in the pipeline for us to review," Hahn said during a press briefing on Tuesday.

The US Administration launched in May Operation Warp Speed, a joint project of Health and Defense Departments, which aims to deliver 300 million doses of a vaccine for COVID-19 by January 2021.

The country's top pandemics expert Anthony Fauci warned on Tuesday, however, that there is no certainty the United States will be able to develop a vaccine against COVID-19 that works and will be safe.

Data on vaccine effectiveness, he added, may be available in the winter or early next year.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.